127 related articles for article (PubMed ID: 540088)
21. [Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
Zhu L; Lu JH; Xie Q; Wu YL; Zhu LP; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun; 45(6):444-9. PubMed ID: 21055319
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
23. Effect of immunotherapy: treatment with mite and other aeroallergens in Thai allergic patients.
Choovoravech P
J Med Assoc Thai; 1980 Sep; 63(9):506-11. PubMed ID: 7420002
[No Abstract] [Full Text] [Related]
24. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
Tari MG; Mancino M; Monti G
Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
26. Changes in thymus- and activation-regulated chemokine (TARC) associated with allergen immunotherapy in patients with perennial allergic rhinitis.
Takeuchi H; Yamamoto Y; Kitano H; Enomoto T
J Investig Allergol Clin Immunol; 2005; 15(3):172-6. PubMed ID: 16261952
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of immunotherapy by nasal antigen challenge.
Cengizlier R; Saraçlar Y; Tomaç N
J Otolaryngol; 1999 Aug; 28(4):185-8. PubMed ID: 10461254
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
29. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
30. [Immunotherapy is effective in the treatment of allergic rhinitis. Retrospective study of 67 cases].
Bleda C; Soler R; Romaguera A; Mas S; Juan JM
Acta Otorrinolaringol Esp; 1998; 49(5):369-72. PubMed ID: 9717325
[TBL] [Abstract][Full Text] [Related]
31. House dust mites in the West Indies.
Hansen RL; Marx JJ; Twiggs JT; Gray RL
Ann Allergy; 1991 Apr; 66(4):320-3. PubMed ID: 2014932
[TBL] [Abstract][Full Text] [Related]
32. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
[TBL] [Abstract][Full Text] [Related]
33. [House dust mite allergy].
Urbanek R; Behrle M; Kuhn W
Padiatr Padol; 1991; 26(1):25-30. PubMed ID: 2057207
[TBL] [Abstract][Full Text] [Related]
34. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
[TBL] [Abstract][Full Text] [Related]
35. A new method of administration of topical nasal extracts. Immunoaerosol therapy.
Sánchez Palacios A; Sánchez Palacios MA; García Marrero JA
Allergol Immunopathol (Madr); 1992; 20(4):135-8. PubMed ID: 1485592
[TBL] [Abstract][Full Text] [Related]
36. [The evaluation of hyposensitization with house dust in patients with nasal allergy to house dust-mite].
Ukai K; Amesara R; Masuda S; Nakamoto S; Ohkawa C; Okamoto K; Sakakura Y
Arerugi; 1994 Jan; 43(1):16-21. PubMed ID: 8147704
[TBL] [Abstract][Full Text] [Related]
37. [Effects of immunotherapy on cytokine production from peripheral blood mononuclear cells in patient with house dust mite allergic rhinitis].
Ishii K; Asakura K; Kataura A
Arerugi; 1999 Apr; 48(4):480-5. PubMed ID: 10355154
[TBL] [Abstract][Full Text] [Related]
38. [Serum IgG and IgG4 antibody production specific to Dermatophagoides farinae in patients with nasal allergy].
Kitao Y
Arerugi; 1985 Oct; 34(10):911-21. PubMed ID: 4091662
[No Abstract] [Full Text] [Related]
39. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
40. The early effect of specific immunotherapy on lymphocyte response to PHA and allergens in atopic patients with allergic rhinitis.
Kinikli G; Tülek N; Sentürk T; Turgay M; Tutkak H; Duman M; Tokgöz G
Allergol Immunopathol (Madr); 1996; 24(2):65-9. PubMed ID: 8933891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
